FDA approves Amgen drug for prevention of migraines

Share this post

(Reuters) – Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug to prevent migraine headaches in adults.

This post was syndicated from Reuters: Health News. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply